Omnicell Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Omnicell's estimated annual revenue is currently $605.4M per year.(i)
  • Omnicell's estimated revenue per employee is $196,000

Employee Data

  • Omnicell has 3089 Employees.(i)

Omnicell's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
VPReveal Email/Phone
3
Sr. VP, Corporate Responsibility And Chief Compliance & Privacy OfficerReveal Email/Phone
4
Chief StaffReveal Email/Phone
5
VP Customer Experience StrategyReveal Email/Phone
6
VP Software EngineeringReveal Email/Phone
7
VP Architecture (Applications and Cloud Platform)Reveal Email/Phone
8
VP Human ResourcesReveal Email/Phone
9
VP, Professional ServicesReveal Email/Phone
10
VP, People Strategist, DEIB, Corporate HRReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$67.1M226N/AN/AN/A
#2
$2M20N/AN/AN/A
#3
$9.6M53N/AN/AN/A
#4
$392M1931N/AN/AN/A
#5
$16.7M11913%$51.5MN/A
#6
$47.2M159N/AN/AN/A
#7
$278.6M737N/AN/AN/A
#8
$1.6M10N/AN/AN/A
Add Company

What Is Omnicell?

keywords:saas

N/A

Total Funding

3089

Number of Employees

$605.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Omnicell News

2022-04-06 - Omnicell to Release First Quarter 2022 Financial Results on ...

Institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and...

2022-03-30 - Omnicell Unveils Innovative IVX Station Robotic ...

Omnicell's completely reimagined, fully automated IV compounding robot is designed to deliver the patient safety, accuracy, cost savings, supply...

2022-03-30 - Omnicell secures deal from Hanmi to distribute innovative ...

Omnicell manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging...

2021-11-02 - Omnicell Announces Financial Results for Third Quarter 2021 - Form 8-K

Omnicell Announces Financial Results for Third Quarter 2021 GAAP and non-GAAP revenues of $296 million GAAP net income per diluted share of $0.61 Non-GAAP net income per diluted share of $1.08 MOUNTAIN VIEW, Calif. -- November 2, 2021 -- Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," ...

2021-07-29 - Omnicell : Announces Financial Results for Second Quarter 2021 (Form 8-K)

Omnicell Announces Financial Results for Second Quarter 2021 Record revenues of $273 million GAAP net income per diluted share of $0.43 Record non-GAAP net income per diluted share of $0.97 MOUNTAIN VIEW, Calif. -- July 29, 2021 -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medicati ...